What is the highest risk period for agranulocytosis after starting therapy?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Master HIV/AIDS Antiretroviral Therapy Test with comprehensive flashcards and multiple-choice questions. Each question provides detailed explanations to enhance your knowledge. Prepare effectively and excel in your exam!

Multiple Choice

What is the highest risk period for agranulocytosis after starting therapy?

Explanation:
Agranulocytosis from drugs that suppress bone marrow tends to appear earliest after therapy begins. The body’s neutrophil production is most vulnerable during the initial exposure, so the highest risk window is the first few months of treatment. Data show the peak risk occurs within about six months (roughly 26 weeks), which is when you must monitor most closely. After this early period, the risk does not remain as high, though rare cases can still occur later, so ongoing monitoring is still important but the peak danger is front-loaded in the first half-year.

Agranulocytosis from drugs that suppress bone marrow tends to appear earliest after therapy begins. The body’s neutrophil production is most vulnerable during the initial exposure, so the highest risk window is the first few months of treatment. Data show the peak risk occurs within about six months (roughly 26 weeks), which is when you must monitor most closely. After this early period, the risk does not remain as high, though rare cases can still occur later, so ongoing monitoring is still important but the peak danger is front-loaded in the first half-year.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy